EVIDENCE LIBRARY
Clonazepam and minocycline in CO2 panic experiments: behavioral and breathing outcomes separated
A translational paper found that two drugs could influence panic-related behavior differently from their effects on ventilation.
A translational paper found that two drugs could influence panic-related behavior differently from their effects on ventilation.
The animal and human components
In mice, carbon dioxide exposure activated microglia in the locus coeruleus and produced hyperventilation and escape-like behavior. Both minocycline and clonazepam reduced escape expression during the challenge, but only minocycline reduced the hyperventilatory response.
The human component studied carbon dioxide responsiveness in people with panic disorder. Minocycline reduced challenge-related panic severity and was associated with changes in selected immune markers. These experimental findings were used to explore an inflammatory contribution to panic responses.
A challenge model has a defined scope
A reduction in visible escape behavior is not identical to normalization of breathing. That distinction matters when behavior is used as a proxy for an internal state. Mouse responses, isolated immune measures, and induced human panic also answer different questions.
The paper does not establish that an antibiotic should replace established panic treatment or that laboratory challenge responses predict long-term clinical benefit. It likewise cannot determine impairment from clonazepam in an individual. Its useful contribution is mechanistic: behavioral, respiratory, and immune outcomes need separate reporting rather than being combined into a general claim that one treatment “stopped panic.”
Source paper
Original analysis of the supplied journal article, identified as PMC12923763.